Updated Guidance on Religious Accommodations to COVID-19 Vaccine Mandates – JD Supra

Updated Guidance on Religious Accommodations to COVID-19 Vaccine Mandates – JD Supra

Athira Pharma to Present Overview and Update from ACT-AD Phase 2 Trial of Fosgonimeton (ATH-1017) in Mild-to-Moderate Alzheimer’s Disease at…
Imcyse to Present at Oppenheimer 32nd Annual Healthcare Conference
XORTX Therapeutics Announces Submission of Clinical Trial Application to Conduct Bridging Pharmacokinetics Study
AVEO Oncology Reports Full Year and Fourth Quarter 2021 Financial Results
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
Myriad Genetics Advances Precision Oncology with New Precise™ Solutions, Combines Genetic Insights from Multiple Tests to Guide Treatment Decisions…
Abeona Therapeutics Achieves Target Enrollment in Pivotal Phase 3 VIITAL™ Study of EB-101 in RDEB
BridgeBio Pharma Announces Positive Phase 2 Data for Limb-girdle Muscular Dystrophy Type 2i (LGMD2i)
Paratek Pharmaceuticals Announces Full-Year 2021 Revenue of $130.2 Million
Crinetics Pharmaceuticals Appoints Caren Deardorf to Board of Directors